Medigene AG provided earnings guidance for the year 2023. The company expects revenue in 2023 to be between EUR 5 million and EUR 7 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 EUR | -4.95% | +4.35% | -5.57% |
05-08 | Medigene Boosts Share Capital Via Rights Offering, Private Placement | MT |
05-02 | Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 - Targeted T Cell Receptor | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.57% | 39.99M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Provides Earnings Guidance for the Year 2023